Literature DB >> 30057363

Metabolomic changes in vertebrate host during malaria disease progression.

Soumita Ghosh1, Sulabha Pathak2, Haripalsingh M Sonawat3, Shobhona Sharma2, Arjun Sengupta4.   

Abstract

Metabolomics refers to top-down systems biological analysis of metabolites in biological specimens. Phenotypic proximity of metabolites makes them interesting candidates for studying biomarkers of environmental stressors such as parasitic infections. Moreover, the host-parasite interaction directly impinges upon metabolic pathways since the parasite uses the host metabolite pool as a biosynthetic resource. Malarial infection, although not recognized as a classic metabolic disorder, often leads to severe metabolic changes such as hypoglycemia and lactic acidosis. Thus, metabolomic analysis of the infection has become an invaluable tool for promoting a better understanding of the host-parasite interaction and for the development of novel therapeutics. In this review, we summarize the current knowledge obtained from metabolomic studies of malarial infection in rodent models and human patients. Metabolomic analysis of experimental rodent malaria has provided significant insights into the mechanisms of disease progression including utilization of host resources by the parasite, sexual dimorphism in metabolic phenotypes, and cellular changes in host metabolism. Moreover, these studies also provide proof of concept for prediction of cerebral malaria. On the other hand, metabolite analysis of patient biofluids generates extensive data that could be of use in identifying biomarkers of infection severity and in monitoring disease progression. Through the use of metabolomic datasets one hopes to assess crucial infection-specific issues such as clinical severity, drug resistance, therapeutic targets, and biomarkers. Also discussed are nascent or newly emerging areas of metabolomics such as pre-erythrocytic stages of the infection and the host immune response. This review is organized in four broad sections-methodologies for metabolomic analysis, rodent infection models, studies of human clinical specimens, and potential of immunometabolomics. Data summarized in this review should serve as a springboard for novel hypothesis testing and lead to a better understanding of malarial infection and parasite biology.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immunometabolomics; Malaria; Metabolism; Metabolites; Metabolomics

Mesh:

Substances:

Year:  2018        PMID: 30057363     DOI: 10.1016/j.cyto.2018.07.022

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

Review 1.  Recent metabolomic developments for antimalarial drug discovery.

Authors:  Lúcia Mamede; Fanta Fall; Matthieu Schoumacher; Allison Ledoux; Pascal De Tullio; Joëlle Quetin-Leclercq; Michel Frédérich
Journal:  Parasitol Res       Date:  2022-10-04       Impact factor: 2.383

2.  Insights into malaria pathogenesis gained from host metabolomics.

Authors:  Heather N Colvin; Regina Joice Cordy
Journal:  PLoS Pathog       Date:  2020-11-12       Impact factor: 6.823

Review 3.  From Metabolite to Metabolome: Metabolomics Applications in Plasmodium Research.

Authors:  Xinyu Yu; Gaoqian Feng; Qingfeng Zhang; Jun Cao
Journal:  Front Microbiol       Date:  2021-01-11       Impact factor: 5.640

Review 4.  Mining the Human Host Metabolome Toward an Improved Understanding of Malaria Transmission.

Authors:  Regina Joice Cordy
Journal:  Front Microbiol       Date:  2020-02-14       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.